138 related articles for article (PubMed ID: 19318677)
1. Apoptosis-related (survivin, Bcl-2), tumor suppressor gene (p53), proliferation (Ki-67), and non-receptor tyrosine kinase (Src) markers expression and correlation with clinicopathologic variables in 60 thymic neoplasms.
Khoury T; Arshad A; Bogner P; Ramnath N; Zhang S; Chandrasekhar R; Wilding G; Alrawi S; Tan D
Chest; 2009 Jul; 136(1):220-228. PubMed ID: 19318677
[TBL] [Abstract][Full Text] [Related]
2. Proliferative activity and apoptosis in thymic epithelial neoplasms.
Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H
Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
[TBL] [Abstract][Full Text] [Related]
3. Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours.
Pan CC; Chen PC; Wang LS; Lee JY; Chiang H
Histopathology; 2003 Aug; 43(2):165-72. PubMed ID: 12877732
[TBL] [Abstract][Full Text] [Related]
4. [Surgery for thymomas and thymic carcinomas; treatment results in terms of WHO histologic typing, Masaoka staging system, and p53 expression].
Yamazaki K; Kitada M; Sasaki K; Koshiko S; Hirasawa M; Ozawa K; Kajiura Y; Sasajima T; Miyokawa N
Kyobu Geka; 2002 Oct; 55(11):949-52. PubMed ID: 12391691
[TBL] [Abstract][Full Text] [Related]
5. [Detection of Epstein-Barr virus, cell proliferation and apoptosis in thymic tumors].
Mai S; Xiong M; Zong Y; Li Z; Rao H
Zhonghua Bing Li Xue Za Zhi; 1999 Apr; 28(2):89-92. PubMed ID: 11869513
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53, mdm2, p21/waf1 and bcl-2 proteins in thymomas.
Stefanaki K; Rontogianni D; Kouvidou CH; Bolioti S; Delides G; Pantelidaki A; Sotsiou F; Kanavaros P
Histopathology; 1997 Jun; 30(6):549-55. PubMed ID: 9205859
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
8. [Upregulation of survivin in non-small cell lung cancer and its clinicopathological correlation with p53 and Bcl-2].
Han PH; Li XJ; Qin H; Yao J; DU N; Ren H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):710-3. PubMed ID: 19664395
[TBL] [Abstract][Full Text] [Related]
9. p53, cellular proliferation, and apoptosis-related factors in thymic neuroendocrine tumors.
Gal AA; Sheppard MN; Nolen JD; Cohen C
Mod Pathol; 2004 Jan; 17(1):33-9. PubMed ID: 14631373
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic significance of p53, Ki-67, and Bcl-2 expression in Tunisian gastric adenocarcinomas.
Ayed DB; Khabir A; Abid M; Bayrouti MI; Gargouri A; Sellami-Boudawara T; Mokdad-Gargouri R
Acta Histochem; 2014 Oct; 116(8):1244-50. PubMed ID: 25095748
[TBL] [Abstract][Full Text] [Related]
11. Expression of Ki-67, Bcl-2, Survivin and p53 Proteins in Patients with Pulmonary Carcinoma.
Halasova E; Adamkov M; Matakova T; Vybohova D; Antosova M; Janickova M; Singliar A; Dobrota D; Jakusova V
Adv Exp Med Biol; 2013; 756():15-21. PubMed ID: 22836614
[TBL] [Abstract][Full Text] [Related]
12. Steroid receptor expression in thymomas and thymic carcinomas.
Mimae T; Tsuta K; Takahashi F; Yoshida A; Kondo T; Murakami Y; Okada M; Takeuchi M; Asamura H; Tsuda H
Cancer; 2011 Oct; 117(19):4396-405. PubMed ID: 21437890
[TBL] [Abstract][Full Text] [Related]
13. KI-67 antigen expression predicts survival and correlates with histologic subtype in the WHO classification of thymic epithelial tumors.
Comin CE; Messerini L; Novelli L; Boddi V; Dini S
Int J Surg Pathol; 2004 Oct; 12(4):395-400. PubMed ID: 15494865
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic analysis of 52 cases of thymic epithelial tumor].
Ma YQ; Miao N; Abulajiang G; Li QX; Liu X; Zhang W; Wang CF; Wang J
Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):249-54. PubMed ID: 20654124
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of expression of P-glycoprotein and inhibitor of apoptosis proteins to chemosensitivity in gastrointestinal carcinoma tissues].
Han J; Tan BB; Geng W; Lu BR; Zhao JH
Ai Zheng; 2008 Nov; 27(11):1166-71. PubMed ID: 19000447
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of apoptosis markers and involvement of chemokine CXCR4 in skin Merkel cell carcinoma.
Tucci MG; Lucarini G; Giangiacomi M; Zizzi A; Criante P; Ricotti G; Biagini G
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1220-5. PubMed ID: 17062035
[TBL] [Abstract][Full Text] [Related]
17. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
18. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC
Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.
Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Chikhlikar PR; Ghosh N; Trivedi TI
Ann Surg Oncol; 2000 May; 7(4):305-11. PubMed ID: 10819372
[TBL] [Abstract][Full Text] [Related]
20. Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy.
Karam JA; Lotan Y; Karakiewicz PI; Ashfaq R; Sagalowsky AI; Roehrborn CG; Shariat SF
Lancet Oncol; 2007 Feb; 8(2):128-36. PubMed ID: 17267327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
